Lexeo Therapeutics

Organisation

Develops

LX1001
clinicaltrials.gov
LX1001
clinicaltrials.gov
LX2006
AAVrh.10hFXNir.lexeotx.com

Trials

Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease
Phase 1Active, not recruiting202310 people1 Jun 2022clinicaltrials.gov
Gene Therapy for APOE4 Homozygote of Alzheimer's Disease
Phase 1/2Completed201915 people16 Aug 2018clinicaltrials.gov